This World Alzheimer’s Month, we have published new data revealing that people living with undiagnosed dementia attend A&E three times more than those without the condition.
Alzheimer’s Society will be investing £10million into funding three new Doctoral Training Centres designed to support and nurture dementia researchers at the start of their career.
Chief Marketing Officer, Alex Hyde-Smith, explains why a second airing of our advert The Long Goodbye is important to highlight the devastating impact of dementia on people's lives.
The MHRA have approved lecanemab for some people with early-stage Alzheimer’s disease. However NICE does not recommend use on the NHS for any patients.